Company Filing History:
1 out of 832,891 Years Active: 2017
Title: Antonios Kolocouris: Innovator in Antiviral Compounds
Introduction
Antonios Kolocouris is a notable inventor based in Athens, Greece. He has made significant contributions to the field of antiviral research, particularly in developing compounds that can treat and prevent viral infections.
Latest Patents
Kolocouris holds a patent for antiviral compounds that are useful in treating and preventing viral infections, including influenza. His patent discloses methods for treating or preventing viral infections, specifically focusing on aminoadamantane derivatives that are structurally analogous to amantadine. These compounds, including spirocyclic variants, are designed to treat amantadine-insensitive influenza infections in subjects.
Career Highlights
Throughout his career, Antonios Kolocouris has demonstrated a commitment to advancing antiviral therapies. His innovative work has the potential to impact public health significantly, especially in the context of influenza outbreaks.
Collaborations
Kolocouris has collaborated with notable colleagues, including David D. Busath and Brent A. Johnson, to further his research and development efforts in antiviral compounds.
Conclusion
Antonios Kolocouris is a distinguished inventor whose work in antiviral compounds showcases his dedication to improving treatment options for viral infections. His contributions are vital in the ongoing battle against influenza and other viral diseases.